A randomized Phase II trial of High Dose-Rate (HDR) and Low Dose-Rate (LDR) brachytherapy as monotherapy in localized prostate cancer: analysis of initial arms of Canadian cancer trials group PR19 (NCT02960087)
Gerard Morton, É. Vigneault, Maroie Barkati, Joelle Helou, Tamim Niazi, J. Robinson, D.A. Loblaw, Chia-Chih Tseng, Hyun‐Tai Chung, Guila Delouya, Cynthia Ménard, A.G. Martin, Peter Chung, Deidre Batchelar, Michael Brundage, Kimberly Whelan, Keyue Ding, Wendy R. Parulekar